Life Sciences & Health Care

Article

Unleash AI's potential

Measuring the return from pharmaceutical innovation 2024

Our report series Measuring the return from pharmaceutical innovation has provided insights into the productivity of biopharma R&D since 2010. We have expanded our analysis over time and our data set now covers the top 20 companies by 2020 R&D spend.

Article

The Future of Health in Europe

How technology and prevention will drive more equitable and sustainable outcomes for all

Article

The business case for Patient Companion Solutions

Patient companion solutions benefit various healthcare stakeholders, including providers, payers, and pharmaceutical companies. The global market for disease management apps was worth USD 8.7 billion in 2022 and is projected to grow at a rate of 12.3% annually from 2023 to 2030.

Perspectives

What’s next for Health Care Professional (HCP) Engagement?

Health Care Professional (HCP) ‘engagement’ describes the model of how biopharma companies engage with their customers and typically covers a broad range of synchronized front line and back-office activities.

Article

Urgency in addressing women’s health – Breaking barriers and promoting Equity

FemTechnology (FemTech) Summit 2023: Environmental, Social, and Governance alignment on women’s health

Analysis

Investment in eye health to prevent sight loss

Investment in eye health to prevent sight loss – presents an in-depth comparison of publicly available data to understand the relationship between investment in eye health and eye outcomes across eight high-income and two low-medium-income countries.

Article

Commercial Operations in Life Sciences

Driving simplification and efficiency across Commercial Operations

Digital transformation of commercial operations has transitioned from a “nice-to-have” enabler to a “must-have” capability, making it critical for Life Science companies to evaluate how digital tools will deliver customer centricity and service innovation across the commercial operations value chain

Article

Segmentation and growth factors of the global neuroscience market

Sizing the brain

The report breaks down the Global Neuroscience Market (GNM) across segments and geographies. It provides a comprehensive analysis of available diagnostic and treatment options – as a proxy for market size – to estimate the revenue-based valuation of the GNM until 2026.

Perspectives

Advanced digital health care providers segmentation

Elevating customer understanding leveraging AI

Our advanced segmentation approach enables to define data-driven HCP segments by leveraging AI and machine learning algorithms. We display a detailed use case that describes how we have helped biopharma companies leverage data and AI to build differentiated and actionable HCP segments.

Article

2023 Global Human Capital Trends

Perspectives

Digital therapeutics

Catalysing the future of health

Digital therapeutics are a novel category of medical interventions that have the potential to disrupt the future of healthcare models

Article

Patient Equality in Health

Making patients equal partners

Watch perspectives and insights of thought leaders and industry shapers on what it would mean to make patients equal partners in healthcare.

Article

Realising a biotech’s potential

What is required to scale successfully?

Article

2023 Global Health Care Outlook

The pandemic that changed everything

Article

The future of health

How innovation will blur traditional health care boundaries

Article

Accelerating the Future of Health

COVID-19 responses from the health ecosystem

Responding to COVID-19 is an enormous challenge for companies of all sizes and in all sectors, not least life sciences. The pandemic is affecting the pharmaceutical ecosystem and highlighting the importance of health technology economically, politically, and socially.

Article

Time to care

Securing a future for the hospital workforce in Europe

Predictions

The future awakens

Life Sciences and Health Care Predictions 2022